Sync2020-logos Virtual_v10-02

PLENARY SESSIONS

SYNC 2020 Plenary Sessions

SYNC 2020’s expansive program will feature 60+ sessions, including 3 Plenary Sessions addressing:
  • SYNCing Syndemics
  • SYNCing on Aging, HIV, and PrEP
  • SYNCing to End the Epidemics

SYNCing to End the HIV Epidemic During the COVID-19 Pandemic

Wednesday - September 9, 2020 / 10:00 AM - 11:30 AM ET

This plenary will sync government agencies on Ending the HIV Epidemic (EHE) initiative during COVID-19.  Ending the HIV Epidemic: A Plan for America (EHE) set an ambitious goal of harnessing the most powerful HIV prevention and treatment tools and leveraging advanced surveillance strategies to end the HIV epidemic in the United States by 2030. COVID-19 has complicated efforts as much of the public health workforce has been diverted to assist with the pandemic response. Hear from the lead EHE implementers, CDC, HRSA, BPHC, SAMHSA, HUD, and IHS as the leaders of the government health care agencies will discuss the latest updates on the Ending the HIV Epidemic implementation and how the community refocuses and re-engages in EHE midst of COVID-19.  Federal leaders will discuss how their agencies are advancing the EHE initiative while responding to the COVID-19 pandemic.

Learning Objectives

    • Discuss and sync activities and approaches of the federal agencies on Ending the HIV Epidemic implementation.
    • Identify how COVID-19 has impacted Ending the HIV Epidemic implementation.
    • Discuss how the federal agencies are leveraging responses to address COVID-19.

The agenda for this session* (Click (+) below to view presenters and moderators. * = Invited):

    • Admiral Giroir, Health and Human Services (HIV, HCV, and COVID)*
    • Harold Phillips, Health and Human Services* (Moderator)
    • Jonathan Mermin, National Center for HIV/AIDS, Centers for Disease Control and Prevention*
    • Laura Cheever, Health Resources and Services Administration, HIV/AIDS Bureau*: Discussing HIV care and treatment and linkage of people with HIV who are either newly diagnosed, or are diagnosed but currently not in care, to the essential HIV care, treatment, and support services needed to help them achieve and maintain an undetectable viral load.
    • Jim Macrae, Health Resources and Services Administration, Bureau of Primary Health Care
    • Neeraj Gandotra, Substance Abuse and Mental Health Services Administration*: Discussing the intersection of HIV and substance use disorders and ensuring that appropriate and effective behavioral health interventions are implemented.

"Aging, HIV Prevention and Care: SYNCing Clinical, Structural and Practical Implications"
Presented by Gilead Sciences

Thursday - September 10, 2020 / 10:00 AM - 11:30 AM ET

During this dynamic plenary, presenters will provide insights on the clinical, structural, and practical aspects of HIV prevention and care among aging populations. The clinical section will cover data and contextualize the needs of aging populations, prevention, and HIV care. The structural component will review health systems and best practices within care coordination for aging PLWH. The practical component will provide patient advocate insights on aging, HIV, and comprehensive prevention for people over 50.

The agenda for this session* (Click (+) below to view presenters and moderators. * = Invited):

    • Darwin Thompson, Gilead Sciences, Inc., Moderator
    • Douglas Brooks, Gilead Sciences, Inc., Moderator
    • Dr. Jon Appelbaum, Florida State University College of Medicine
      ○   Reflections on HealthHIV’s Inaugural State of Aging with HIV Survey
      ○   Implications of age on the disease progression of HIV
    • Dr. Bisola Ojikutu, Harvard Medical School*

      ○   Stigma within healthcare settings
      ○   Gay African-American and Latin men and comprehensive prevention at the macro-level, and population-level implications

    • Melanie Anne Haskin Reese, Older Women Embracing Life (OWEL)*
    • Tez Anderson, Let’s Kick Ass*
    • Gabrielle “Gibby” Thomas*’
    • Edward Jackson, University of Alabama at Birmingham, Center for AIDS Research
    • Michelle Lopez, Gay Men’s Health Crisis
    • Kym Gordon, Damien Ministries*
    • Frank Hawkins, AIDS Delaware
    • Darwin Thompson, Gilead Sciences, Inc.
    • Douglas Brooks, Gilead Sciences, Inc.

SYNCing Syndemics and Health Equity: From HIV, STDs and HCV to Opioids and COVID-19

Friday - September 11, 2020 / 10:00 AM - 11:30 AM ET

The epidemics of HIV, sexually-transmitted diseases (STDs), hepatitis C (HCV), opioid misuse and overdose are widely recognized as a syndemic in the U.S. Access to health care services and medication assisted treatment of opioid use disorders, income inequality, housing disparities, intensity of policing activities, employment status, and healthcare policies, are all related to the prevalence of substance misuse, overdoses, infection risk and morbidity. With the COVID-19 virus overwhelmingly targeting people who would already be vulnerable to disease, it is important to also examine how it’s interaction with other epidemics may exacerbate the disease burden in certain populations and increase health vulnerability. Panelists will highlight the importance of examining and addressing structural factors, health disparities and health equity to respond to the syndemic of HIV, HCV, opioids, and COVID-19 and how structural factors are addressed through intervention and policy to reduce vulnerability of at-risk areas and populations.

Learning Objectives:

    • Recognize the HIV, hepatitis C (HCV), opioid misuse, and overdose epidemics as a syndemic, and examine the intersection of COVID-19.
    • Identify how health disparities exacerbate syndemics in vulnerable areas and populations.
    • Discuss strategies to address structural factors impacting vulnerable areas and populations in order to respond to the syndemics.

Panelists (* = Invited):

    • Dr. Fauci will discuss where we are in COVID-19 response, impact on vulnerable populations (and its intersection with HIV).
    • Syndemic of HIV, STDs, HCV and opioid misuse epidemics, disproportionately-impacted populations, and addressing structural factors
    • Structural factors impacting rise of STDs, intersection of HIV, HCV and opioid misuse epidemics/impacted populations